All stock lists
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.64+$0.01 (+2.17%)
Market cap
$38.9M
Insider Score
Health Score
Analyst consensus
Listed since
May 2, 2014
Website
Insider Score
91/ 100
ALDX Insider Score
Bullish2 qualifying trades · 2 insiders · $135.40K bought in the last 90 days
ALDX analyst forecast
ALDX analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ALDX 12-month price target
No published price targets in the last 12 months.
Best analysts covering ALDX
- BTIG0%success rate · -54.9% avg return · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ALDX analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-09-30 |
| — | BTIG | Buy | — | — | Reiterated | 2026-09-29 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2026-03-18 |
ALDX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-27 | -$0.14 | -$0.11 | $4.8M | $0 |
| 2026-05-07 | -$0.13 | -$0.06 | $0 | $0 |
| 2026-08-06 | -$0.09 | -$0.09 | $31.3M | $0 |
| 2026-11-05 | -$0.11 | -$0.06 | $2.5M | $0 |
| 2027-02-26Upcoming | -$0.06 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.